AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 35136296 — intervention group
Group type: EXPERIMENTAL
Intervention: Targeted fluid therapy (Group-T)
Number of subjects: 40
Study 35136296 — intervention group
Group type: COMPARATOR
Intervention: Standard fluid therapy (Group-S)
Number of subjects: 40
Study 33026192 — intervention group
Group type: EXPERIMENTAL
Intervention: Support arm (clinicians endorsed and offered referral to a weight loss programme)
Number of subjects: 1882
Study 33026192 — intervention group
Group type: EXPERIMENTAL
Intervention: Advice arm (advised that weight loss would improve health)
Number of subjects: 1882
Study 33026192 — intervention group
Group type: COMPARATOR
Intervention: Both arms (support and advice)
Number of subjects: 1882
Study 35285674 — intervention group
Group type: EXPERIMENTAL
Intervention: Balance It
Number of subjects: 30
Study 35285674 — intervention group
Group type: EXPERIMENTAL
Intervention: Bubble Pop
Number of subjects: 30
Study 35285674 — intervention group
Group type: EXPERIMENTAL
Intervention: Scoop'd
Number of subjects: 30
Study 35285674 — intervention group
Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 30
Study 32822218 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate workload condition (level 3)
Number of subjects: 50
Study 32822218 — intervention group
Group type: EXPERIMENTAL
Intervention: Lead time of 7 seconds
Number of subjects: 50
Study 32822218 — intervention group
Group type: COMPARATOR
Intervention: Lower workload conditions (level 1 and level 2)
Number of subjects: 50
Study 32822218 — intervention group
Group type: COMPARATOR
Intervention: Higher workload condition (level 4)
Number of subjects: 50
Study 32944800 — intervention group
Group type: EXPERIMENTAL
Intervention: Lipegfilgrastim
Number of subjects: 101
Study 32944800 — intervention group
Group type: COMPARATOR
Intervention: Pegfilgrastim
Number of subjects: 101
Study 32409830 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative chemoradiotherapy followed by surgery plus adjuvant chemotherapy
Number of subjects: 110
Study 32409830 — intervention group
Group type: COMPARATOR
Intervention: Surgery plus adjuvant chemotherapy (standard treatment)
Number of subjects: 110
Study 32409830 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative chemoradiotherapy
Number of subjects: 110
Study 34619066 — intervention group
Group type: EXPERIMENTAL
Intervention: Supportive text messages
Number of subjects: 324
Study 34619066 — intervention group
Group type: COMPARATOR
Intervention: Control group (no text messages)
Number of subjects: 324
Study 34697252 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate aerobic exercise (EXE)
Number of subjects: 32
Study 34697252 — intervention group
Group type: EXPERIMENTAL
Intervention: EXE + RAD
Number of subjects: 32
Study 34697252 — intervention group
Group type: COMPARATOR
Intervention: Control group (exposure to an experimental phone without battery)
Number of subjects: 32
Study 34697252 — intervention group
Group type: EXPERIMENTAL
Intervention: RAD (exposure to 900/1800 MHz radiofrequency electromagnetic waves 3 hours per day)
Number of subjects: 32
Study 34810344 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic curd
Number of subjects: 40
Study 34810344 — intervention group
Group type: COMPARATOR
Intervention: Synbiotic curd
Number of subjects: 40
Study 35092599 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharmacist-led intervention
Number of subjects: 184
Study 35092599 — intervention group
Group type: COMPARATOR
Intervention: Control group (routine education and support)
Number of subjects: 184
Study 33293394 — intervention group
Group type: EXPERIMENTAL
Intervention: No antenatal care (ANC) visit
Number of subjects: 603
Study 33293394 — intervention group
Group type: EXPERIMENTAL
Intervention: No postnatal care (PNC) visit
Number of subjects: 603
Study 35270204 — intervention group
Group type: EXPERIMENTAL
Intervention: Strengths and Empowerment (RISE)
Number of subjects: 58
Study 35270204 — intervention group
Group type: COMPARATOR
Intervention: Enhanced Care as Usual (ECAU)
Number of subjects: 58
Study 34810385 — intervention group
Group type: EXPERIMENTAL
Intervention: Flexible Spiral Wire (FSW)
Number of subjects: 40
Study 34810385 — intervention group
Group type: COMPARATOR
Intervention: Ceramic Interlocking Retainer
Number of subjects: 40
Study 32470239 — intervention group
Group type: EXPERIMENTAL
Intervention: PBM followed by the application of nHAP (GLasernHAP)
Number of subjects: 32
Study 32470239 — intervention group
Group type: EXPERIMENTAL
Intervention: Simulated PBM followed by the application of nHAP (GnHAP)
Number of subjects: 32
Study 32470239 — intervention group
Group type: COMPARATOR
Intervention: Simulated PBM followed by nHAP-free toothpaste (GPlacebo)
Number of subjects: 32
Study 32470239 — intervention group
Group type: COMPARATOR
Intervention: PBM followed by nHAP-free toothpaste (GLaser)
Number of subjects: 32
Study 34352146 — intervention group
Group type: EXPERIMENTAL
Intervention: MFU‐V combined with L‐HA injection (combined technique)
Number of subjects: 46
Study 34352146 — intervention group
Group type: COMPARATOR
Intervention: MFU‐V monotherapy (single technique)
Number of subjects: 46
Study 32542370 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous iron sucrose (200 mg Venofer® in 100 ml saline on days 1, 3, and 5)
Number of subjects: 253
Study 32542370 — intervention group
Group type: COMPARATOR
Intervention: Placebo (100 ml saline)
Number of subjects: 253
Study 32542370 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous iron sucrose
Number of subjects: 253
Study 32542370 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 253
Study 33208325 — intervention group
Group type: EXPERIMENTAL
Intervention: Zinc biofortified wheat flour (target zinc concentration of 40 mg/kg)
Number of subjects: 482
Study 33208325 — intervention group
Group type: COMPARATOR
Intervention: Locally procured wheat flour from standard varieties (expected zinc concentration of 20 mg/kg)
Number of subjects: 482
Study 33208325 — intervention group
Group type: EXPERIMENTAL
Intervention: Zinc biofortified wheat flour
Number of subjects: 482
Study 33208325 — intervention group
Group type: COMPARATOR
Intervention: Locally procured wheat flour from standard varieties
Number of subjects: 482
Study 36223203 — intervention group
Group type: EXPERIMENTAL
Intervention: K9 springs
Number of subjects: 30
Study 36223203 — intervention group
Group type: COMPARATOR
Intervention: Ballista springs
Number of subjects: 30
Study 33648568 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone 20 mg intravenously once daily on days 1-5, followed by 10 mg on days 6-10
Number of subjects: 300
Study 33648568 — intervention group
Group type: COMPARATOR
Intervention: Dexamethasone 6 mg intravenously once daily on days 1-10
Number of subjects: 300
Study 33648568 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone 20 mg
Number of subjects: 300
Study 35487723 — intervention group
Group type: EXPERIMENTAL
Intervention: Genetics Adviser + brief genetic counselling session
Number of subjects: 140
Study 35487723 — intervention group
Group type: COMPARATOR
Intervention: Genetic counselling alone
Number of subjects: 140
Study 34021043 — intervention group
Group type: EXPERIMENTAL
Intervention: Closed-loop neurofeedback (cNF) training
Number of subjects: 0
Study 34021043 — intervention group
Group type: EXPERIMENTAL
Intervention: Closed-loop neurofeedback (cNF) training in children with ADHD
Number of subjects: 0
Study 35171122 — intervention group
Group type: EXPERIMENTAL
Intervention: DoCTRINE checklist (intervention group)
Number of subjects: 108
Study 35171122 — intervention group
Group type: COMPARATOR
Intervention: Control group (no checklist)
Number of subjects: 108
Study 35171122 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (intervention and control)
Number of subjects: 108
Study 35171122 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall interrater agreement
Number of subjects: 108
Study 35171122 — intervention group
Group type: EXPERIMENTAL
Intervention: Accepted vs rejected submissions
Number of subjects: 108
Study 34162769 — intervention group
Group type: EXPERIMENTAL
Intervention: One-step knife (OSK)
Number of subjects: 51
Study 34162769 — intervention group
Group type: COMPARATOR
Intervention: Conventional knife (CK)
Number of subjects: 51
Study 35462372 — intervention group
Group type: EXPERIMENTAL
Intervention: Desidustat 100 mg oral tablets thrice a week for 24 weeks
Number of subjects: 588
Study 35462372 — intervention group
Group type: COMPARATOR
Intervention: Biosimilar darbepoetin subcutaneous injection 0.75 μg/kg once in 2 weeks for 24 weeks
Number of subjects: 588
Study 35462372 — intervention group
Group type: EXPERIMENTAL
Intervention: Desidustat
Number of subjects: 588
Study 35462372 — intervention group
Group type: COMPARATOR
Intervention: Darbepoetin
Number of subjects: 588
Study 34217249 — intervention group
Group type: EXPERIMENTAL
Intervention: Neo-adjuvant radiotherapy (NRT)
Number of subjects: 5272
Study 34217249 — intervention group
Group type: COMPARATOR
Intervention: Non-neo-adjuvant radiotherapy (non-NRT)
Number of subjects: 5272
Study 33984220 — intervention group
Group type: EXPERIMENTAL
Intervention: Upper-body forced-air blanket
Number of subjects: 120
Study 33984220 — intervention group
Group type: COMPARATOR
Intervention: Lower-body forced-air blanket
Number of subjects: 120
Study 35177442 — intervention group
Group type: EXPERIMENTAL
Intervention: Supplementary feeding for MAM infants
Number of subjects: 198
Study 33449843 — intervention group
Group type: EXPERIMENTAL
Intervention: Fractional CO2 laser
Number of subjects: 39
Study 33449843 — intervention group
Group type: COMPARATOR
Intervention: Fractional Er:YAG laser
Number of subjects: 39
Study 32320405 — intervention group
Group type: EXPERIMENTAL
Intervention: DREAMS Partnership
Number of subjects: 1687
Study 36440678 — intervention group
Group type: EXPERIMENTAL
Intervention: Education program (7-hours self-directed learning; 3-hour online workshop)
Number of subjects: 49
Study 36440678 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control
Number of subjects: 49
Study 35877056 — intervention group
Group type: EXPERIMENTAL
Intervention: Mentoring from Big Brothers Big Sisters of America (BBBS) affiliates
Number of subjects: 188
Study 35877056 — intervention group
Group type: COMPARATOR
Intervention: Non-compliers (adolescents in the intervention group who did not receive a mentor)
Number of subjects: 188
Study 35877056 — intervention group
Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 188
Study 33580472 — intervention group
Group type: EXPERIMENTAL
Intervention: Omega-3 fatty acids treatment for 16 weeks
Number of subjects: 40
Study 35229668 — intervention group
Group type: EXPERIMENTAL
Intervention: Ofatumumab
Number of subjects: 1969
Study 35229668 — intervention group
Group type: COMPARATOR
Intervention: Teriflunomide (newly switched)
Number of subjects: 1969
Study 36447623 — intervention group
Group type: EXPERIMENTAL
Intervention: Immersive Virtual Reality (VR) therapy
Number of subjects: 60
Study 36447623 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard neurological rehabilitation + VR therapy
Number of subjects: 60
Study 36447623 — intervention group
Group type: COMPARATOR
Intervention: Schultz's Autogenic Training (SAT)
Number of subjects: 60
Study 33558352 — intervention group
Group type: EXPERIMENTAL
Intervention: Tai chi exercise intervention for 24 weeks
Number of subjects: 106
Study 33558352 — intervention group
Group type: COMPARATOR
Intervention: Health education control for 24 weeks
Number of subjects: 106
Study 33558352 — intervention group
Group type: EXPERIMENTAL
Intervention: fMRI and P300 measurements at baseline and 24 weeks
Number of subjects: 106
Study 36170320 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified conventional drilling technique
Number of subjects: 30
Study 36170320 — intervention group
Group type: COMPARATOR
Intervention: Conventional drilling technique
Number of subjects: 30
Study 36170320 — intervention group
Group type: COMPARATOR
Intervention: Simplified drilling technique
Number of subjects: 30
Study 34916467 — intervention group
Group type: EXPERIMENTAL
Intervention: 600 mg rifampin
Number of subjects: 10
Study 34916467 — intervention group
Group type: EXPERIMENTAL
Intervention: 900 mg rifampin
Number of subjects: 10
Study 34916467 — intervention group
Group type: EXPERIMENTAL
Intervention: 1200 mg rifampin
Number of subjects: 10
Study 34916467 — intervention group
Group type: EXPERIMENTAL
Intervention: All doses of rifampin
Number of subjects: 10
Study 35973185 — intervention group
Group type: EXPERIMENTAL
Intervention: High total / low simple carbohydrate diet (HTLS)
Number of subjects: 98
Study 35973185 — intervention group
Group type: COMPARATOR
Intervention: High total / high simple carbohydrate diet (HTHS)
Number of subjects: 98
Study 34551948 — intervention group
Group type: COMPARATOR
Intervention: Standard pulmonary rehabilitation (PR) with sham inspiratory muscle training (IMT)
Number of subjects: 138
Study 34551948 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard pulmonary rehabilitation (PR) added to inspiratory muscle training (IMT)
Number of subjects: 138
Study 34032304 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal oxytocin (24 IU)
Number of subjects: 40
Study 34032304 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 32951460 — intervention group
Group type: EXPERIMENTAL
Intervention: Nomogram for predicting cause-specific survival (CSS) probabilities for TSCC patients.
Number of subjects: 7243
Study 32951460 — intervention group
Group type: EXPERIMENTAL
Intervention: Calibration plots and decision-curve analysis (DCA) for the nomogram.
Number of subjects: 7243
Study 32749625 — intervention group
Group type: EXPERIMENTAL
Intervention: Web-based cognitive training program
Number of subjects: 58
Study 32749625 — intervention group
Group type: COMPARATOR
Intervention: Attention control training
Number of subjects: 58
Study 34154470 — intervention group
Group type: EXPERIMENTAL
Intervention: Parenting training (6 sessions of 120 minutes each) in addition to routine clinical care
Number of subjects: 80
Study 34154470 — intervention group
Group type: COMPARATOR
Intervention: Routine clinical care
Number of subjects: 80
Study 34004161 — intervention group
Group type: EXPERIMENTAL
Intervention: Plasma and SAAT-derived exosomes from OB-NAFLD group
Number of subjects: 70
Study 34004161 — intervention group
Group type: EXPERIMENTAL
Intervention: Proinflammatory macrophages and CD4/CD8 T-cell populations in SAAT
Number of subjects: 70
Study 34004161 — intervention group
Group type: EXPERIMENTAL
Intervention: Plasma PAI-1 concentrations
Number of subjects: 70
Study 34004161 — intervention group
Group type: COMPARATOR
Intervention: 24-hour plasma cytokine concentration areas-under-the-curve
Number of subjects: 70
Study 34004161 — intervention group
Group type: COMPARATOR
Intervention: Percentage of proinflammatory macrophages and plasma PAI-1 concentration areas-under-the-curve
Number of subjects: 70
Study 36412403 — intervention group
Group type: EXPERIMENTAL
Intervention: Gemcitabine (150 mg/m2 weekly)
Number of subjects: 60
Study 36412403 — intervention group
Group type: COMPARATOR
Intervention: Cisplatin (35 mg/m2 weekly)
Number of subjects: 60
Study 33590475 — intervention group
Group type: EXPERIMENTAL
Intervention: Motivational Interview‐Enhanced Safety Plan (MI‐SP) + Texts
Number of subjects: 80
Study 33590475 — intervention group
Group type: COMPARATOR
Intervention: MI‐SP + Texts
Number of subjects: 80
Study 33590475 — intervention group
Group type: EXPERIMENTAL
Intervention: Booster calls
Number of subjects: 80
Study 33590475 — intervention group
Group type: COMPARATOR
Intervention: MI‐SP alone
Number of subjects: 80
Study 35248721 — intervention group
Group type: EXPERIMENTAL
Intervention: Prebiotics
Number of subjects: 60
Study 35248721 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 32993388 — intervention group
Group type: EXPERIMENTAL
Intervention: Nintedanib
Number of subjects: 0
Study 32993388 — intervention group
Group type: EXPERIMENTAL
Intervention: Pirfenidone
Number of subjects: 0
Study 32993388 — intervention group
Group type: EXPERIMENTAL
Intervention: Current pharmacological treatments
Number of subjects: 0
Study 32993388 — intervention group
Group type: EXPERIMENTAL
Intervention: Emerging pharmacological treatments
Number of subjects: 0
Study 32993388 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination therapies
Number of subjects: 0
Study 34263511 — intervention group
Group type: EXPERIMENTAL
Intervention: People living with HIV (PLWH)
Number of subjects: 14134
Study 34263511 — intervention group
Group type: COMPARATOR
Intervention: Uninfected controls
Number of subjects: 14134
Study 32832225 — intervention group
Group type: EXPERIMENTAL
Intervention: MI-OCT feedback (group B)
Number of subjects: 24
Study 32832225 — intervention group
Group type: COMPARATOR
Intervention: No MI-OCT feedback (group A)
Number of subjects: 24
Study 36102267 — intervention group
Group type: EXPERIMENTAL
Intervention: Bilateral asymmetric lateral rectus recession
Number of subjects: 80
Study 36102267 — intervention group
Group type: COMPARATOR
Intervention: Unilateral lateral rectus recession and medial rectus resection
Number of subjects: 80
Study 33956945 — intervention group
Group type: EXPERIMENTAL
Intervention: SARS-CoV-2 infections screening
Number of subjects: 720
Study 33956945 — intervention group
Group type: EXPERIMENTAL
Intervention: IgG seroreactivity assessment
Number of subjects: 720
Study 33956945 — intervention group
Group type: EXPERIMENTAL
Intervention: Common cold-resembling symptoms assessment
Number of subjects: 720
Study 32416022 — intervention group
Group type: EXPERIMENTAL
Intervention: High-risk chief complaints (CCs)
Number of subjects: 21953
Study 32416022 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-risk chief complaints (CCs)
Number of subjects: 21953
Study 35550261 — intervention group
Group type: EXPERIMENTAL
Intervention: BNT162b2 (30 μg in 0.30 mL; full dose)
Number of subjects: 166
Study 35550261 — intervention group
Group type: EXPERIMENTAL
Intervention: mRNA-1273 (50 μg in 0.25 mL; half dose)
Number of subjects: 166
Study 34886071 — intervention group
Group type: EXPERIMENTAL
Intervention: Exposure to tweets about harms of e-cigarettes (various levels of misinformation)
Number of subjects: 2400
Study 34886071 — intervention group
Group type: EXPERIMENTAL
Intervention: Exposure to tweets about harms of e-cigarettes
Number of subjects: 2400
Study 34996427 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified Bakay technique (MT)
Number of subjects: 160
Study 34996427 — intervention group
Group type: COMPARATOR
Intervention: Standard colpotomy (ST)
Number of subjects: 160
Study 34838094 — intervention group
Group type: COMPARATOR
Intervention: Assessment interviews (part of the control group)
Number of subjects: 15
Study 32814500 — intervention group
Group type: EXPERIMENTAL
Intervention: QR code-based video education program accessed multiple times on smartphones
Number of subjects: 335
Study 32814500 — intervention group
Group type: COMPARATOR
Intervention: Control group watched the same video on a tablet once
Number of subjects: 335
Study 35487299 — intervention group
Group type: EXPERIMENTAL
Intervention: Esomeprazole 40 mg/day
Number of subjects: 21
Study 35487299 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study 33370370 — intervention group
Group type: EXPERIMENTAL
Intervention: Experiential learning program after dementia supporter training
Number of subjects: 81
Study 33370370 — intervention group
Group type: COMPARATOR
Intervention: Dementia supporter training only (control group)
Number of subjects: 81
Study 33370370 — intervention group
Group type: EXPERIMENTAL
Intervention: Experiential learning program
Number of subjects: 81
Study 35061999 — intervention group
Group type: EXPERIMENTAL
Intervention: Trainer in residence professional development program
Number of subjects: 139
Study 35061999 — intervention group
Group type: EXPERIMENTAL
Intervention: Postprogram observations
Number of subjects: 139
Study 33831942 — intervention group
Group type: EXPERIMENTAL
Intervention: Bladder instillation with triamcinolone acetonide
Number of subjects: 90
Study 33831942 — intervention group
Group type: COMPARATOR
Intervention: Bladder instillation without triamcinolone acetonide
Number of subjects: 90
Study 35076639 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive training (hour-long dual N-back and attention network tasks, 5 days per week for 4 weeks)
Number of subjects: 29
Study 35076639 — intervention group
Group type: COMPARATOR
Intervention: Control group (no cognitive training)
Number of subjects: 29
Study 33617863 — intervention group
Group type: COMPARATOR
Intervention: motion-sensing, hands-free gaming device plus traditional rehabilitation (TR)
Number of subjects: 50
Study 33617863 — intervention group
Group type: COMPARATOR
Intervention: task-oriented training (TOT) plus traditional rehabilitation (TR)
Number of subjects: 50
Study 33617863 — intervention group
Group type: EXPERIMENTAL
Intervention: traditional rehabilitation (TR)
Number of subjects: 50
Study 616120592 — intervention group
Group type: EXPERIMENTAL
Intervention: EBI‐005 (5 or 20 mg/mL)
Number of subjects: 74
Study 616120592 — intervention group
Group type: COMPARATOR
Intervention: Vehicle control
Number of subjects: 74
Study 35298522 — intervention group
Group type: EXPERIMENTAL
Intervention: Manual therapy
Number of subjects: 64
Study 35298522 — intervention group
Group type: EXPERIMENTAL
Intervention: Hot pack treatment
Number of subjects: 64
Study 35298522 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 64
Study 32416201 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise-based cardiac rehabilitation (CR+)
Number of subjects: 524
Study 32416201 — intervention group
Group type: COMPARATOR
Intervention: Control group (CR-)
Number of subjects: 524
Study 34792290 — intervention group
Group type: EXPERIMENTAL
Intervention: Acceptance and Commitment Therapy (ACT) sessions (n = 67)
Number of subjects: 135
Study 34792290 — intervention group
Group type: COMPARATOR
Intervention: Standard information only (Control group, n = 68)
Number of subjects: 135
Study 33227224 — intervention group
Group type: EXPERIMENTAL
Intervention: Photobiomodulation therapy (PBMT) applied over 14 sites per lower limb immediately before 1500 m run, delivering 30 J per site, total energy dose of 840 J.
Number of subjects: 19
Study 33227224 — intervention group
Group type: EXPERIMENTAL
Intervention: Photobiomodulation therapy (PBMT)
Number of subjects: 19
Study 33227224 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study 34643888 — intervention group
Group type: EXPERIMENTAL
Intervention: Multi-strain probiotic (PRO group)
Number of subjects: 200
Study 34643888 — intervention group
Group type: COMPARATOR
Intervention: Control group (CON group)
Number of subjects: 200
Study 34496859 — intervention group
Group type: EXPERIMENTAL
Intervention: Multi-component intervention (self-monitoring of steps with counselling support)
Number of subjects: 188
Study 34496859 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-component intervention (self-monitoring of steps without counselling support)
Number of subjects: 188